Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$2.1 - $4.83 $11,722 - $26,961
5,582 Added 26.43%
26,703 $115,000
Q4 2023

Feb 13, 2024

BUY
$1.12 - $3.73 $23,655 - $78,781
21,121 New
21,121 $64,000
Q2 2023

Aug 14, 2023

BUY
$2.46 - $3.14 $56,223 - $71,764
22,855 New
22,855 $56,000
Q2 2022

Aug 08, 2022

BUY
$4.04 - $8.51 $69,084 - $145,521
17,100 New
17,100 $84,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.